[HTML][HTML] EUROPEAN CONSENSUS-BASED INTERDISCIPLINARY GUIDELINE FOR DIAGNOSIS AND TREATMENT OF BASAL CELL CARCINOMA–UPDATE 2023

K Peris, MC Fargnoli, R Kaufmann… - European Journal of …, 2023 - Elsevier
Basal cell carcinoma (BCC) is the most common malignant tumour in white populations.
Multi-disciplinary experts from European Association of Dermato-Oncology (EADO) …

[HTML][HTML] Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management.

AG Marzuka, SE Book - The Yale journal of biology and medicine, 2015 - europepmc.org
Basal cell carcinoma (BCC) is the most common malignancy. Exposure to sunlight is the
most important risk factor. Most, if not all, cases of BCC demonstrate overactive Hedgehog …

Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention

MC Cameron, E Lee, BP Hibler, CN Giordano… - Journal of the American …, 2019 - Elsevier
As the most common human cancer worldwide and continuing to increase in incidence,
basal cell carcinoma is associated with significant morbidity and cost. Continued advances …

Topical pharmacotherapy for skin cancer: part II. Clinical applications

G Micali, F Lacarrubba, MR Nasca, S Ferraro… - Journal of the American …, 2014 - Elsevier
The purpose of the paper is to provide an in-depth, evidence-based analysis of the clinical
use of topical treatments for skin cancer. A comprehensive review of topical drugs has been …

Consensus for nonmelanoma skin cancer treatment, part II: squamous cell carcinoma, including a cost analysis of treatment methods

ANB Kauvar, CJ Arpey, G Hruza, SM Olbricht… - Dermatologic …, 2015 - journals.lww.com
BACKGROUND Cutaneous squamous cell carcinoma (cSCC) is the second most common
cancer in the United States. Cutaneous squamous cell carcinoma has an estimated …

Sebaceous carcinoma: review of the literature

RL Kyllo, KL Brady, EA Hurst - Dermatologic Surgery, 2015 - journals.lww.com
BACKGROUND Sebaceous carcinoma is an uncommon adnexal neoplasm with a
documented capability for regional and distant metastasis. Traditionally, sebaceous …

Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining …

JR Etzkorn, JF Sobanko, R Elenitsas… - Journal of the American …, 2015 - Elsevier
Background Various methods of tissue processing have been used to treat melanoma with
Mohs micrographic surgery (MMS). Objective We describe a method of treating melanoma …

Association of patient risk factors, tumor characteristics, and treatment modality with poor outcomes in primary cutaneous squamous cell carcinoma: a systematic …

GA Zakhem, AN Pulavarty, J Carucci… - JAMA …, 2023 - jamanetwork.com
Importance Primary cutaneous squamous cell carcinoma is usually curable; however, a
subset of patients develops poor outcomes, including local recurrence, nodal metastasis …

Management of high-risk and advanced basal cell carcinoma

S Puig, A Berrocal - Clinical and Translational Oncology, 2015 - Springer
Despite that basal cell carcinoma (BCC) is curative in the vast majority of cases, some
patients are at high risk of recurrence and, in a few patients, lesions can progress to a point …

Evidence-based clinical practice guidelines for microcystic adnexal carcinoma: informed by a systematic review

B Worley, JL Owen, CA Barker, R Behshad… - JAMA …, 2019 - jamanetwork.com
Importance Microcystic adnexal carcinoma (MAC) occurs primarily in older adults of white
race/ethnicity on sun-exposed skin of the head and neck. There are no formal guiding …